Takeda’s USD 4bn psoriasis pill helped clear skin in mid-stage study

A psoriasis drug that Takeda acquired last month was safe in a mid-stage placebo-controlled study. 
By Kanoko Matsuyama, bloomberg

Takeda Pharmaceutical Co.’s newly purchased oral psoriasis drug was safe and effective in a mid-stage study, highlighting its potential for treating the painful, incurable skin condition.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading